Prognostic value of 12-leads admission electrocardiogram in low-risk patients hospitalized for COVID-19.


Journal

Minerva medica
ISSN: 1827-1669
Titre abrégé: Minerva Med
Pays: Italy
ID NLM: 0400732

Informations de publication

Date de publication:
Aug 2022
Historique:
pubmed: 12 11 2021
medline: 3 8 2022
entrez: 11 11 2021
Statut: ppublish

Résumé

Cardiac involvement significantly contributes to coronavirus disease 2019 (COVID-19) mortality.12-lead electrocardiogram (ECG) represents a fast, cheap, and easy to perform exam with the adjunctive advantage of the remote reporting possibility. In this study, we sought to investigate if electrocardiographic parameters can identify patients, deemed at low-risk at admission, who will face in-hospital unfavorable course. From March 1, 2020, through March 30, 2021, 384 consecutive patients with confirmed low-risk COVID-19 were hospitalized at the University Hospital of Bari (Italy). Criteria for low risk were: admission to the division of Pneumology or Infectious Diseases, no need for immediate (within 24 hours from admission) transfer to Intensive Care Unit or for respiratory support with invasive mechanical ventilation (IMV) or for circulation support (either mechanical or pharmacological). Admission ECGs were reviewed and interpreted by two expert cardiologists. The primary outcomes were in-hospital death and the composite outcome of in-hospital death and IMV. In low-risk COVID-19 patients, atrial fibrillation (AF), poor R wave progression (PRWP), tachycardia, and right bundle branch block (RBBB) resulted as statistically significant and independent predictors of in-hospital all-cause mortality; AF, PRWP, Tachycardia, RBBB, and corrected QT interval showed to be statistically significant and independent risk factors for the occurrence of the composite endpoint of death and IMV. Our study demonstrated for the first time that RBBB and PRWP, assessed upon admission with ECG, are associated with unfavorable clinical course in a baseline low-risk population hospitalized for COVID-19.

Sections du résumé

BACKGROUND BACKGROUND
Cardiac involvement significantly contributes to coronavirus disease 2019 (COVID-19) mortality.12-lead electrocardiogram (ECG) represents a fast, cheap, and easy to perform exam with the adjunctive advantage of the remote reporting possibility. In this study, we sought to investigate if electrocardiographic parameters can identify patients, deemed at low-risk at admission, who will face in-hospital unfavorable course.
METHODS METHODS
From March 1, 2020, through March 30, 2021, 384 consecutive patients with confirmed low-risk COVID-19 were hospitalized at the University Hospital of Bari (Italy). Criteria for low risk were: admission to the division of Pneumology or Infectious Diseases, no need for immediate (within 24 hours from admission) transfer to Intensive Care Unit or for respiratory support with invasive mechanical ventilation (IMV) or for circulation support (either mechanical or pharmacological). Admission ECGs were reviewed and interpreted by two expert cardiologists. The primary outcomes were in-hospital death and the composite outcome of in-hospital death and IMV.
RESULTS RESULTS
In low-risk COVID-19 patients, atrial fibrillation (AF), poor R wave progression (PRWP), tachycardia, and right bundle branch block (RBBB) resulted as statistically significant and independent predictors of in-hospital all-cause mortality; AF, PRWP, Tachycardia, RBBB, and corrected QT interval showed to be statistically significant and independent risk factors for the occurrence of the composite endpoint of death and IMV.
CONCLUSIONS CONCLUSIONS
Our study demonstrated for the first time that RBBB and PRWP, assessed upon admission with ECG, are associated with unfavorable clinical course in a baseline low-risk population hospitalized for COVID-19.

Identifiants

pubmed: 34761885
pii: S0026-4806.21.07894-0
doi: 10.23736/S0026-4806.21.07894-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

667-674

Auteurs

Martino Pepe (M)

Section of Cardiovascular Diseases, Department of Emergency and Organ Transplantation (DETO), Aldo Moro University of Bari, Bari, Italy - drmartinopepe@gmail.com.

Gianluigi Napoli (G)

Section of Cardiovascular Diseases, Department of Emergency and Organ Transplantation (DETO), Aldo Moro University of Bari, Bari, Italy.

Gaetano Brindicci (G)

Clinic of Infectious Diseases, Policlinic Hospital of Bari, Bari, Italy.

Eugenio Carulli (E)

Section of Cardiovascular Diseases, Department of Emergency and Organ Transplantation (DETO), Aldo Moro University of Bari, Bari, Italy.

Palma L Nestola (PL)

Section of Cardiovascular Diseases, Department of Emergency and Organ Transplantation (DETO), Aldo Moro University of Bari, Bari, Italy.

Carmen R Santoro (CR)

Clinic of Infectious Diseases, Policlinic Hospital of Bari, Bari, Italy.

Giuseppe Biondi-Zoccai (G)

Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University, Latina, Italy.
Mediterranea Cardiocentro, Naples, Italy.

Arturo Giordano (A)

Unit of Invasive Cardiology, Pineta Grande Hospital, Castel Volturno, Caserta, Italy.

Fabrizio D'Ascenzo (F)

Division of Cardiology, Department of Medical Sciences, Molinette Hospital, Città della Salute e della Scienza, Turin, Italy.

Plinio Cirillo (P)

Division of Cardiology, University of Naples Federico II, Naples, Italy.

Annalisa Saracino (A)

Clinic of Infectious Diseases, Policlinic Hospital of Bari, Bari, Italy.
Department of Biomedical Sciences and Human Oncology, Aldo Moro University of Bari, Bari, Italy.

Stefano Favale (S)

Section of Cardiovascular Diseases, Department of Emergency and Organ Transplantation (DETO), Aldo Moro University of Bari, Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH